BCDA
USDBioCardia Inc. Common Stock
السعر في الوقت الحقيقي
مخطط الأسعار
المقاييس الرئيسية
مقاييس السوق
الافتتاح
$1.410
الأعلى
$1.410
الأدنى
$1.320
الحجم
0.07M
أساسيات الشركة
القيمة السوقية
14.1M
الصناعة
التكنولوجيا الحيوية
البلد
United States
إحصاءات التداول
متوسط الحجم
0.60M
البورصة
NCM
العملة
USD
نطاق 52 أسبوعاً
أخبار ذات صلة
HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $25 Price Target
HC Wainwright & Co. analyst Joseph Pantginis reiterates BioCardia with a Buy and maintains $25 price target.
BioCardia Announces Pricing of Up To $12 Million Public Offering
SUNNYVALE, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (NASDAQ:BCDA) ("BioCardia" or the "Company"), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and
BioCardia Announces CardiAMP Chronic Myocardial Ischemia Trial Top Line Data of Roll-in Cohort Show Improved Exercise Tolerance and Reduced Angina Episodes at Six-Month Primary Follow-up
SUNNYVALE, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ:BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the
BioCardia CEO Peter Altman to Present at the H. C. Wainwright 27th Annual Global Investment Conference in New York City September 8-10, 2025
SUNNYVALE, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- - BioCardia®, Inc. (NASDAQ:BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today
أسهم ذات صلة
ATUS
Altice USA Inc.
PMTU
PennyMac Mortgage Investment Trust 8.50% Senior Notes due 2028
WENA
ANEW MEDICAL INC.
UAVS
AgEagle Aerial Systems Inc.
HFRO
Highland Opportunities and Income Fund Common Shares of Beneficial Interest
ابق على اطلاع
تعيين تنبيهات الأسعار، الحصول على تحديثات تحليل الذكاء الاصطناعي وأخبار السوق في الوقت الحقيقي.